Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 6 institutions in 3 countries.
Tatjana P StanojkovicDepartment of Experimental Oncology, Institute of Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.
Marina FilimonovaA. Tsyb Medical Radiological Research Center, Federal State Budget Institution National Medical Research Radiological Center of the Ministry of Healthcare of the Russian Federation, 249031 Obninsk, Russia.ORCID 0000-0002-9690-4746
Nadja GrozdanicDepartment of Experimental Oncology, Institute of Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-2543-0838
Slavica PetovicInstitute of Marine Biology, University of Montenegro, 85330 Kotor, Montenegro.
Anna ShitovaA. Tsyb Medical Radiological Research Center, Federal State Budget Institution National Medical Research Radiological Center of the Ministry of Healthcare of the Russian Federation, 249031 Obninsk, Russia.
Olga SoldatovaA. Tsyb Medical Radiological Research Center, Federal State Budget Institution National Medical Research Radiological Center of the Ministry of Healthcare of the Russian Federation, 249031 Obninsk, Russia.ORCID 0000-0002-1178-3560
Alexander FilimonovA. Tsyb Medical Radiological Research Center, Federal State Budget Institution National Medical Research Radiological Center of the Ministry of Healthcare of the Russian Federation, 249031 Obninsk, Russia.
Jelena VladicFaculty of Technology, University of Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0002-3891-7266
Petr ShegayNational Medical Research Radiological Center of the Ministry of Health of the Russian Federation, 249030 Obninsk, Russia.
Andrey KaprinNational Medical Research Radiological Center of the Ministry of Health of the Russian Federation, 249030 Obninsk, Russia.
Sergey IvanovA. Tsyb Medical Radiological Research Center, Federal State Budget Institution National Medical Research Radiological Center of the Ministry of Healthcare of the Russian Federation, 249031 Obninsk, Russia.
Marina NikitovicDepartment of Experimental Oncology, Institute of Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.
Ministry of Health of the Russian Federation · RUOncology Institute of Vojvodina · RSPeoples' Friendship University of Russia · RUUniversity of Belgrade · RSUniversity of Montenegro · MEUniversity of Novi Sad · RS
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
The goal of this study was to determine the activity in vitro and in vivo of avarol, a sesquiterpene hydroquinone originating from the
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Evaluation of In Vitro Cytotoxic Potential of Avarol towards Human Cancer Cell Lines and In Vivo Antitumor Activity in Solid Tumor Models. · full record | OpenQuestion